Vestibulotoxicity with gentamicin

BMJ. 2022 Sep 7:378:e070873. doi: 10.1136/bmj-2022-070873.

Authors

Karina Ferreira¹, Suzanne Forbes², Diego Kaski³

Affiliations

¹ Department of Audiology, Ear Nose & Throat Eastman Dental Hospitals, London, UK.
² Royal London Hospital, Barts Health NHS Trust, London, UK.
³ Department of Clinical and Movement Neurosciences, University College London, London, UK d.kaski@ucl.ac.uk.

PMID: 36779589
DOI: 10.1136/bmj-2022-070873

No abstract available

MeSH terms

Anti-Bacterial Agents / adverse effects
Gentamicins* / adverse effects
Humans
Vestibular Diseases*

Substances

Gentamicins
Anti-Bacterial Agents